CLINICAL_TRIALS
trial_result
· 2019-10-03
Clinical Trial Update: A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia [Phase 2, Phase 3]
Summary
A dose-finding study of OPC-34712 in schizophrenia completed (Phase 2/Phase 3).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Schizophrenia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-10-03